About Orange Grove Bio LLC
Orange Grove Bio LLC is a company based in New York (United States) founded in 2019 by Lutz B Giebel. Orange Grove Bio LLC has raised $16.59 million across 1 funding round. Orange Grove Bio LLC offers products and services including Drug Development Platform, Platelet Preservation Additive, and Gene Therapy Platform. Orange Grove Bio LLC operates in a competitive market with competitors including Orakl Oncology, Oncodesign, LumaBridge, Lytica Therapeutics and Axios Biosciences, among others.
- Headquarter New York, United States
- Founders Lutz B Giebel
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Orange Grove Bio Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$16.59 M (USD)
in 1 rounds
-
Latest Funding Round
$16.59 M (USD), Series B
Aug 25, 2022
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Orange Grove Bio LLC
Orange Grove Bio LLC offers a comprehensive portfolio of products and services, including Drug Development Platform, Platelet Preservation Additive, and Gene Therapy Platform.
Platform for accelerating drug development through university partnerships
Additive enabling long-term platelet storage to address blood supply challenges
Non-viral platform for treating genetic diseases like cystic fibrosis
People of Orange Grove Bio LLC
Unlock access to complete
Unlock access to complete
Funding Insights of Orange Grove Bio LLC
Orange Grove Bio LLC has successfully raised a total of $16.59M through 1 strategic funding round. The most recent funding activity was a Series B round of $16.59 million completed in August 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Orange Grove Bio LLC
Investment portfolio details for Orange Grove Bio LLC
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Orange Grove Bio LLC
Detailed financials for Orange Grove Bio LLC
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Orange Grove Bio Llc Comparisons
Peer comparison for Orange Grove Bio LLC
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Orange Grove Bio LLC
Orange Grove Bio LLC operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Orakl Oncology, Oncodesign, LumaBridge, Lytica Therapeutics and Axios Biosciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Orakl Oncology is a precision oncology start-up that enables the emergence of rare oncology by connecting patient tumors to the world's 3rd best cancer center.
|
|
| Locked | Locked | Locked |
Preclinical assessment services for anti-cancer therapies are provided.
|
|
| Locked | Locked | Locked |
Provider of oncology clinical research, regulatory affairs, and data management services
|
|
| Locked | Locked | Locked |
Therapeutic drugs are developed for medical applications.
|
|
| Locked | Locked | Locked |
Creates innovative platforms for anti-cancer drug development.
|
Detailed competitors of Orange Grove Bio LLC
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Orange Grove Bio Llc
Complete news archive for Orange Grove Bio LLC
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Orange Grove Bio LLC
Orange Grove Bio LLC was founded in 2019 and raised its 1st funding round 3 years after it was founded.
Orange Grove Bio LLC is headquartered in New York, United States. It is registered at New York, New York, United States.
Ryan Fox is the current CEO of Orange Grove Bio LLC.
Orange Grove Bio LLC is a funded company, having raised a total of $16.59M across 1 funding round to date.
Orange Grove Bio LLC provider of preclinical development services through providing healthcare solutions, biopharma outsourcing, cro, preclinical studies, and oncology. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Orange Grove Bio LLC's top competitors include Oncodesign, Orakl Oncology and Lytica Therapeutics.
Orange Grove Bio LLC offers Drug Development Platform, Platelet Preservation Additive, and Gene Therapy Platform.